Works by Visentin, Andrea

Results: 113
    1

    Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 1, p. 30, doi. 10.3390/jcm14010030
    By:
    • Zoletto, Simone;
    • Pizzi, Marco;
    • De Crescenzo, Andrea;
    • Friziero, Alberto;
    • D'Amore, Fabio;
    • Carli, Giuseppe;
    • Vianelli, Nicola;
    • Auteri, Giuseppe;
    • Bertozzi, Irene;
    • Nichele, Ilaria;
    • Binotto, Gianni;
    • Dei Tos, Angelo Paolo;
    • Scarmozzino, Federico;
    • D'Amore, Emanuele S. G.;
    • Ceccato, Jessica;
    • Sabattini, Elena;
    • Cinetto, Francesco;
    • Piazza, Francesco;
    • Visentin, Andrea;
    • Zambello, Renato
    Publication type:
    Article
    2
    3

    The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.

    Published in:
    2019
    By:
    • Visentin, Andrea;
    • Bonaldi, Laura;
    • Rigolin, Gian Matteo;
    • Mauro, Francesca Romana;
    • Martines, Annalisa;
    • Frezzato, Federica;
    • Imbergamo, Silvia;
    • Scomazzon, Edoardo;
    • Pravato, Stefano;
    • Bardi, Maria Antonella;
    • Cavallari, Maurizio;
    • Volta, Eleonora;
    • Cavazzini, Francesco;
    • Nanni, Maurizio;
    • Del Giudice, Ilaria;
    • Facco, Monica;
    • Guarini, Anna;
    • Semenzato, Gianpietro;
    • Foà, Robin;
    • Cuneo, Antonio
    Publication type:
    journal article
    4
    5

    Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 982, doi. 10.1002/ajh.27247
    By:
    • Autore, Francesco;
    • Visentin, Andrea;
    • Deodato, Marina;
    • Vitale, Candida;
    • Galli, Eugenio;
    • Fresa, Alberto;
    • Fazzi, Rita;
    • Sanna, Alessandro;
    • Olivieri, Jacopo;
    • Scortechini, Ilaria;
    • Del Principe, Maria Ilaria;
    • Sportoletti, Paolo;
    • Schiattone, Luana;
    • Maschio, Nilla;
    • Facchinelli, Davide;
    • Marchesi, Francesco;
    • Coscia, Marta;
    • Tedeschi, Alessandra;
    • Trentin, Livio;
    • Innocenti, Idanna
    Publication type:
    Article
    6

    The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 12, p. 1856, doi. 10.1002/ajh.27093
    By:
    • Visentin, Andrea;
    • Chatzikonstantinou, Thomas;
    • Scarfò, Lydia;
    • Kapetanakis, Anargyros;
    • Demosthenous, Christos;
    • Karakatsoulis, Georgios;
    • Minga, Eva;
    • Chamou, Dimitra;
    • Allsup, David;
    • Cabrero, Alejandro Alonso;
    • Andres, Martin;
    • Antic, Darko;
    • Baile, Mónica;
    • Baliakas, Panagiotis;
    • Besikli‐Dimou, Sotiria;
    • Bron, Dominique;
    • Chatzileontiadou, Sofia;
    • Cordoba, Raul;
    • Correa, Juan‐Gonzalo;
    • Cuéllar‐García, Carolina
    Publication type:
    Article
    7

    Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E237, doi. 10.1002/ajh.27009
    By:
    • Visentin, Andrea;
    • Mauro, Francesca Romana;
    • Scarfò, Lydia;
    • Gentile, Massimo;
    • Farina, Lucia;
    • Reda, Gianluigi;
    • Ferrarini, Isacco;
    • Proietti, Giulia;
    • Derenzini, Enrico;
    • Cibien, Francesca;
    • Vitale, Candida;
    • Sanna, Alessandro;
    • Pietrasanta, Daniela;
    • Marchetti, Monia;
    • Murru, Roberta;
    • Rigolin, Gian Matteo;
    • Sportoletti, Paolo;
    • Trimarco, Valentina;
    • Cavarretta, Chiara Adele;
    • Angotzi, Francesco
    Publication type:
    Article
    8

    Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
    By:
    • Molica, Stefano;
    • Giannarelli, Diana;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Frustaci, Anna Maria;
    • Chiarenza, Annalisa;
    • Ciolli, Stefania;
    • Vitale, Candida;
    • Laurenti, Luca;
    • De Paoli, Lorenzo;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Moia, Riccardo;
    • Rigolin, Gian Matteo;
    • Levato, Luciano;
    • Giordano, Annamaria;
    • Del Poeta, Giovanni;
    • Stelitano, Caterina;
    • Deodato, Marina
    Publication type:
    Article
    9

    Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
    By:
    • Visentin, Andrea;
    • Mauro, Francesca Romana;
    • Cibien, Francesca;
    • Vitale, Candida;
    • Reda, Gianluigi;
    • Fresa, Alberto;
    • Ciolli, Stefania;
    • Pietrasanta, Daniela;
    • Marchetti, Monia;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Rigolin, Gian Matteo;
    • Quaglia, Francesca Maria;
    • Scarfò, Lydia;
    • Sportoletti, Paolo;
    • Pravato, Stefano;
    • Piazza, Francesco;
    • Coscia, Marta;
    • Laurenti, Luca;
    • Molica, Stefano
    Publication type:
    Article
    10

    TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E306, doi. 10.1002/ajh.26235
    By:
    • Morabito, Fortunato;
    • Del Poeta, Giovanni;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Bossio, Sabrina;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Visentin, Andrea;
    • Condoluci, Adalgisa;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo;
    • Scortechini, Ilaria;
    • Recchia, Anna Grazia
    Publication type:
    Article
    11

    Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E269, doi. 10.1002/ajh.26201
    By:
    • Morabito, Fortunato;
    • Tripepi, Giovanni;
    • Del Poeta, Giovanni;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Bossio, Sabrina;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Visentin, Andrea;
    • Condoluci, Adalgisa;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo;
    • Scortechini, Ilaria
    Publication type:
    Article
    12

    Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. E168, doi. 10.1002/ajh.26127
    By:
    • Morabito, Fortunato;
    • Tripepi, Giovanni;
    • Del Poeta, Giovanni;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Visentin, Andrea;
    • Condoluci, Adalgisa;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo;
    • Scortechini, Ilaria;
    • Rossi, Francesca Maria
    Publication type:
    Article
    13

    Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 1, p. 58, doi. 10.1002/ajh.24935
    By:
    • Cantoni, Silvia;
    • Carpenedo, Monica;
    • Mazzucconi, Maria Gabriella;
    • De Stefano, Valerio;
    • Carrai, Valentina;
    • Ruggeri, Marco;
    • Specchia, Giorgina;
    • Vianelli, Nicola;
    • Pane, Fabrizio;
    • Consoli, Ugo;
    • Artoni, Andrea;
    • Zaja, Francesco;
    • D'adda, Mariella;
    • Visentin, Andrea;
    • Ferrara, Felicetto;
    • Barcellini, Wilma;
    • Caramazza, Domenica;
    • Baldacci, Erminia;
    • Rossi, Elena;
    • Ricco, Alessandra
    Publication type:
    Article
    14

    Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab.

    Published in:
    2020
    By:
    • Gentile, Massimo;
    • Martino, Enrica Antonia;
    • Visentin, Andrea;
    • Coscia, Marta;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Mauro, Francesca Romana;
    • Laurenti, Luca;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Vigna, Ernesto;
    • Mendicino, Francesco;
    • Lucia, Eugenio;
    • Bossio, Sabrina;
    • Recchia, Anna Grazia;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo
    Publication type:
    Letter
    15

    Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.733848
    By:
    • Manni, Sabrina;
    • Fregnani, Anna;
    • Quotti Tubi, Laura;
    • Spinello, Zaira;
    • Carraro, Marco;
    • Scapinello, Greta;
    • Visentin, Andrea;
    • Barilà, Gregorio;
    • Pizzi, Marco;
    • Dei Tos, Angelo Paolo;
    • Vianello, Fabrizio;
    • Zambello, Renato;
    • Gurrieri, Carmela;
    • Semenzato, Gianpietro;
    • Trentin, Livio;
    • Piazza, Francesco
    Publication type:
    Article
    16
    17

    A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.

    Published in:
    Current Oncology, 2023, v. 30, n. 1, p. 274, doi. 10.3390/curroncol30010022
    By:
    • Visentin, Andrea;
    • Molinari, Maria Chiara;
    • Pravato, Stefano;
    • Cellini, Alessandro;
    • Angotzi, Francesco;
    • Cavaretta, Chiara Adele;
    • Ruocco, Valeria;
    • Imbergamo, Silvia;
    • Piazza, Francesco;
    • Proietti, Giulia;
    • Mauro, Francesca Romana;
    • Trentin, Livio
    Publication type:
    Article
    18
    19
    20
    21

    Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia.

    Published in:
    HemaSphere, 2025, v. 9, n. 1, p. 1, doi. 10.1002/hem3.70094
    By:
    • Frustaci, Anna Maria;
    • Zappaterra, Arianna;
    • Galitzia, Andrea;
    • Visentin, Andrea;
    • Merli, Michele;
    • Rizzi, Rita;
    • Ferrarini, Isacco;
    • Ferrero, Simone;
    • Innao, Vanessa;
    • Baratè, Claudia;
    • Zinzani, Pierluigi;
    • Puccini, Benedetta;
    • Autore, Francesco;
    • Tani, Monica;
    • Ferrari, Angela;
    • Catania, Gioacchino;
    • Nicolosi, Maura;
    • Pasquale, Raffaella;
    • Motta, Marina;
    • Murru, Roberta
    Publication type:
    Article
    22

    CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience.

    Published in:
    HemaSphere, 2024, v. 8, n. 7, p. 1, doi. 10.1002/hem3.128
    By:
    • Bomben, Riccardo;
    • Zucchetto, Antonella;
    • Laureana, Roberta;
    • Chiarenza, Annalisa;
    • Olivieri, Jacopo;
    • Tissino, Erika;
    • Rossi, Francesca M.;
    • Vit, Filippo;
    • Bittolo, Tamara;
    • Papotti, Robel;
    • Pozzo, Federico;
    • Gaglio, Annalisa;
    • Degan, Massimo;
    • Polesel, Jerry;
    • Marasca, Roberto;
    • Visentin, Andrea;
    • Moia, Riccardo;
    • Innocenti, Idanna;
    • Vitale, Candida;
    • Murru, Roberta
    Publication type:
    Article
    23

    Waldenström Macroglobulinemia in Very Elderly (≥75‐year‐old) Patients: A 33‐year‐retrospective Cohort Study in an Italian University Hospital.

    Published in:
    HemaSphere, 2023, v. 7, n. 10, p. e964, doi. 10.1097/HS9.0000000000000964
    By:
    • Danesin, Nicolò;
    • Lo Schirico, Mariella;
    • Scapinello, Greta;
    • Grassi, Angela;
    • Riva, Marcello;
    • Berno, Tamara;
    • Branca, Antonio;
    • Visentin, Andrea;
    • Carraro, Marco;
    • Pavan, Laura;
    • Manni, Sabrina;
    • Bonaldi, Laura;
    • Martines, Annalisa;
    • Bertorelle, Roberta;
    • Vianello, Fabrizio;
    • Gurrieri, Carmela;
    • Briani, Chiara;
    • Zambello, Renato;
    • Trentin, Livio;
    • Piazza, Francesco
    Publication type:
    Article
    24
    25

    P1509: CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND PREVIOUS INFECTIONS HAD IMPACT ON INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH VENETOCLAX: A MULTICENTRE SEIFEM STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972916.91665.6e
    By:
    • Autore, Francesco;
    • Visentin, Andrea;
    • Deodato, Marina;
    • Vitale, Candida;
    • Galli, Eugenio;
    • Fresa, Alberto;
    • Fazzi, Rita;
    • Sanna, Alessandro;
    • Olivieri, Jacopo;
    • Scortechini, Ilaria;
    • Principe, Maria Ilaria DEL;
    • Sportoletti, Paolo;
    • Schiattone, Luana;
    • Maschio, Nilla;
    • Facchinelli, Davide;
    • Coscia, Marta;
    • Tedeschi, Alessandra;
    • Trentin, Livio;
    • Innocenti, Idanna;
    • Candoni, Anna
    Publication type:
    Article
    26

    P1075: ADVANCED‐STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE‐CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971196.13252.3d
    By:
    • Cellini, Alessandro;
    • Adele Cavarretta, Chiara;
    • Angotzi, Francesco;
    • Ruocco, Valeria;
    • Serafin, Andrea;
    • Zatta, Ivan;
    • Gregianin, Michele;
    • Vio, Stefania;
    • Crimì, Filippo;
    • Vianello, Federica;
    • Pizzi, Marco;
    • Pravato, Stefano;
    • Trentin, Livio;
    • Visentin, Andrea
    Publication type:
    Article
    27
    28

    P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, p. 24, doi. 10.1097/01.HS9.0000890784.88764.fa
    By:
    • Visentin, Andrea;
    • Ruggeri, Edoardo;
    • Frezzato, Federica;
    • Pizzi, Marco;
    • Cellini, Alessandro;
    • Angotzi, Francesco;
    • Cavarretta, Chiara Adele;
    • Ruocco, Valeria;
    • Pravato, Stefano;
    • Severin, Filippo;
    • Facco, Monica;
    • Manni, Sabrina;
    • Piazza, Francesci;
    • Trentin, Livio
    Publication type:
    Article
    29

    P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET‐adapted era. A single center retrospective study.

    Published in:
    HemaSphere, 2022, v. 6, p. 3, doi. 10.1097/01.HS9.0000890588.66425.bf
    By:
    • Visentin, Andrea;
    • Cellini, Alessandro;
    • Cavarretta, Chiara Adele;
    • Gargarella, Leila Romano;
    • Angotzi, Francesco;
    • Ruocco, Valeria;
    • Zoletto, Simone;
    • Pravato, Stefano;
    • Pizzi, Marco;
    • Vianello, Federica;
    • Crimì, Filippo;
    • Vio, Stefania;
    • Gregianin, Michele;
    • Trentin, Livio
    Publication type:
    Article
    30
    31

    Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.

    Published in:
    Journal of the Peripheral Nervous System, 2023, v. 28, n. 3, p. 522, doi. 10.1111/jns.12565
    By:
    • Bresciani, Lorenzo;
    • Salvalaggio, Alessandro;
    • Vegezzi, Elisa;
    • Visentin, Andrea;
    • Fortuna, Andrea;
    • Anglani, Mariagiulia;
    • Cacciavillani, Mario;
    • Masciocchi, Stefano;
    • Scaranzin, Silvia;
    • Carecchio, Miryam;
    • Martinuzzi, Andrea;
    • Gastaldi, Matteo;
    • Briani, Chiara
    Publication type:
    Article
    32
    33
    34

    Peripheral nervous system involvement in lymphomas.

    Published in:
    Journal of the Peripheral Nervous System, 2019, v. 24, n. 1, p. 5, doi. 10.1111/jns.12295
    By:
    • Briani, Chiara;
    • Visentin, Andrea;
    • Campagnolo, Marta;
    • Salvalaggio, Alessandro;
    • Ferrari, Sergio;
    • Cavallaro, Tiziana;
    • Manara, Renzo;
    • Gasparotti, Roberto;
    • Piazza, Francesco
    Publication type:
    Article
    35
    36
    37

    Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 5, p. 879, doi. 10.1080/10428194.2024.2446609
    By:
    • Rusconi, Chiara;
    • Barone, Angelica;
    • Visentin, Andrea;
    • Bianchi, Benedetta;
    • Zilioli, Vittorio Ruggero;
    • Bernardelli, Andrea;
    • Iadecola, Sara;
    • Olivari, Edoardo;
    • Rossi, Francesca Gaia;
    • Gotti, Manuel;
    • Cecchetti, Caterina;
    • Puccini, Benedetta;
    • Franceschetti, Silvia;
    • Molteni, Alfredo;
    • Steffanoni, Sara;
    • Marino, Fabrizio;
    • Vanazzi, Anna;
    • Guidetti, Anna;
    • Merli, Michele;
    • Mazzon, Federico
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 5, p. 659, doi. 10.1111/bjh.12815
    By:
    • Frezzato, Federica;
    • Trimarco, Valentina;
    • Martini, Veronica;
    • Gattazzo, Cristina;
    • Ave, Elisa;
    • Visentin, Andrea;
    • Cabrelle, Anna;
    • Olivieri, Valeria;
    • Zambello, Renato;
    • Facco, Monica;
    • Zonta, Francesca;
    • Cristiani, Andrea;
    • Brunati, Anna Maria;
    • Moro, Stefano;
    • Semenzato, Gianpietro;
    • Trentin, Livio
    Publication type:
    Article
    44
    45
    46
    47
    48

    Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70033
    By:
    • Innocenti, Idanna;
    • Tomasso, Annamaria;
    • Giannarelli, Diana;
    • Scarfò, Lydia;
    • Murru, Roberta;
    • Visentin, Andrea;
    • Frustaci, Anna Maria;
    • Morelli, Francesca;
    • Vitale, Candida;
    • Mosca, Antonio;
    • Sanna, Alessandro;
    • Farina, Giuliana;
    • Laureana, Roberta;
    • Gentile, Massimo;
    • Galitzia, Andrea;
    • Pasquale, Raffaella;
    • Autore, Francesco;
    • Olivieri, Jacopo;
    • Romeo, Azzurra;
    • Deodato, Marina
    Publication type:
    Article
    49
    50

    Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3249
    By:
    • Martino, Enrica Antonia;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Laurenti, Luca;
    • Visentin, Andrea;
    • Frustaci, Annamaria;
    • Vigna, Ernesto;
    • Pepe, Sara;
    • Catania, Gioacchino;
    • Loseto, Giacomo;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Sportoletti, Paolo;
    • Del Principe, Maria Ilaria;
    • Laureana, Roberta;
    • Coscia, Marta;
    • Galimberti, Sara;
    • Ferretti, Eleonora;
    • Zucchetto, Antonella;
    • Bomben, Riccardo
    Publication type:
    Article